Mårten Segelmark
21 – 30 of 209
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Drug exposure and subsequent diagnosis with ANCA-associated vasculitis – A population-based case- control study
(2024) p.191-191
- Contribution to conference › Abstract
-
Mark
Data-driven subclassification of ANCA-associated vasculitis : model-based clustering of a federated international cohort
- Contribution to journal › Article
-
Mark
Assisted peritoneal dialysis compared to in-centre hemodialysis – an observational study of outcomes from the Swedish Renal Registry
- Contribution to journal › Article
-
Mark
Epidemiology and clinical characteristics of biopsy-confirmed adult-onset IgA vasculitis in southern Sweden
- Contribution to journal › Article
-
Mark
Using imlifidase to elucidate the characteristics and importance of anti-GBM antibodies produced after start of treatment
(2024) In Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 39(1). p.45-54
- Contribution to journal › Article
-
Mark
Thyroid disease in ANCA-associated vasculitis : a clinical and epidemiological study
- Contribution to journal › Article
-
Mark
A population-based study on the incidence and aetiology of infectious complications in peritoneal dialysis in South Sweden
- Contribution to journal › Article
-
Mark
Imlifidase in kidney transplantation
- Contribution to journal › Scientific review
-
Mark
The HLA region in ANCA-associated vasculitis : characterisation of genetic associations in a Scandinavian patient population
- Contribution to journal › Article
-
Mark
Validation of IgA nephropathy diagnosis in the Swedish Renal Registry
- Contribution to journal › Article
